UPM Pharmaceuticals Appoints Dr. Chi-Chang Wung as Director of Analytical Development

UPM Pharmaceuticals, a Contract Development and Manufacturing Organization (CDMO) focused on oral solid and semi-solid drug dosage forms, has appointed Dr. Chi-Chang Wung to the position of Director of Analytical Development. Dr. Wung will oversee UPM's analytical development group.

Continue reading

Outsourcing Formulation Development & Manufacturing: CDMOs Are Innovating for 21st-Century Medicine

Originally published on 6/6/2018 at Drug Development & Delivery

Continue reading

Scientific Expertise Facilitates Oral Peptide Product Development and Manufacturing

Originally published on 5/29/2018 at Pharma's Almanac

Continue reading

Oral Solid Dosage Manufacturing

Originally published on 5/25/2018 at Pharmaceutical Outsourcing

Continue reading

Five Minutes With Jim Gregory, CEO, UPM Pharmaceuticals – DCAT Week ‘18

UPM Pharmaceuticals CEO- Jim Gregory interviewed by Pharma Horizon Journal during DCAT week 2018.

Continue reading

Facilitating Implementation and Customer Service with Offline Serialization

Originally published on 3/12/2018 at Pharma's Almanac

Continue reading

UPM Pharmaceuticals appoints Daniel Dixon as Vice President of Quality Control

UPM Pharmaceuticals, a Contract Development and Manufacturing Organization (CDMO) focused on solid oral and semi-solid drug dosage forms, has appointed Daniel Dixon to the position of Vice President of Quality Control.  Mr. Dixon will oversee UPM's Analytical Testing & Development groups and the Microbiological & Raw Material Testing Labs.

Continue reading

A CDMO’s Small-Town Environment With Big-Time Operations

Originally published on 11/03/2017 at Pharmaceutical Processing, and appears in the November/December issue of Pharmaceutical Proccessing

Continue reading

UPM Pharmaceuticals appoints Chris Curtin as Chief Operating Officer

UPM Pharmaceuticals, a Contract Development and Manufacturing Organization (CDMO) focused on solid oral and semi-solid dosage forms, has appointed Chris Curtin as Chief Operating Officer. Mr. Curtin was promoted from his previous role as Executive Vice President of Quality Operations. Mr. Curtin will lead the organization responsible for Research & Development, Manufacturing, Quality Assurance, Inventory Management, Quality Control and Analytical Services.

Continue reading

Contractors Take on the Challenge of Complex Molecules

Originally published on 9/01/2018 at Drug Development & Delivery

Continue reading